40
Participants
Start Date
April 30, 1991
Primary Completion Date
December 31, 2007
Study Completion Date
June 30, 2009
allogeneic tumor cell vaccine
autologous tumor cell vaccine
recombinant interferon alfa
recombinant interferon gamma
sargramostim
cyclophosphamide
St. Vincent Medical Center - Los Angeles, Los Angeles
St. Vincent Medical Center - Los Angeles
OTHER